VWR (VWR) Receiving Somewhat Favorable Press Coverage, Analysis Finds

News headlines about VWR (NASDAQ:VWR) have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research firm identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. VWR earned a media sentiment score of 0.17 on Accern’s scale. Accern also assigned news stories about the medical research company an impact score of 46.6953009758273 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

A number of equities research analysts have commented on VWR shares. Zacks Investment Research upgraded VWR from a “hold” rating to a “buy” rating and set a $37.00 target price on the stock in a report on Tuesday, September 12th. BidaskClub cut VWR from a “sell” rating to a “strong sell” rating in a report on Saturday, September 2nd. Finally, ValuEngine upgraded VWR from a “hold” rating to a “buy” rating in a report on Tuesday, November 7th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $31.67.

VWR (NASDAQ:VWR) opened at $33.25 on Friday. The company has a debt-to-equity ratio of 1.09, a current ratio of 1.25 and a quick ratio of 0.79. The firm has a market capitalization of $4,380.00 and a price-to-earnings ratio of 17.32. VWR has a 52-week low of $24.42 and a 52-week high of $37.25.

VWR (NASDAQ:VWR) last issued its earnings results on Tuesday, November 7th. The medical research company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.46 by $0.08. The business had revenue of $1.20 billion for the quarter, compared to analyst estimates of $1.16 billion. VWR had a return on equity of 15.90% and a net margin of 3.27%. The business’s quarterly revenue was up 5.2% on a year-over-year basis. During the same period last year, the company posted $0.44 EPS. analysts predict that VWR will post 1.85 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This report was published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this report on another publication, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this report can be read at https://sportsperspectives.com/2017/12/03/vwr-vwr-receiving-somewhat-favorable-press-coverage-analysis-finds.html.

About VWR

VWR Corporation is a provider of product and service solutions to laboratory and production customers. The Company offers a portfolio of branded and private label laboratory products, services and solutions to the life science, general research and applied markets. The Company operates in two segments: Americas and EMEA-APAC.

Insider Buying and Selling by Quarter for VWR (NASDAQ:VWR)

Receive News & Ratings for VWR Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VWR Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply